Featured Events!


2017 Pre-Filled Syringes Forum

Strategic Development, Safety & Regulatory Compliance, and Commercialization of Pre-Filled Syringes

April 10-11, 2017, Racquet Club of Philadelphia, PA

With the Pre-Filled Syringes market expected to top $16 billion dollars by 2021, the industry is looking for next generation materials, technologies and production strategies to streamline commercialization and to adapt quickly to a changing regulatory environment. Pharma Ed Resources, an industry leader since 2004 in delivering market-driven research on PFS, is proud to announce its 2017 Pre-Filled Syringes Forum. Pharma Ed brings together top scientists, regulatory experts and innovators to share best practices and the latest research in this field, enabling you to maximize your organization's leverage in this dynamic and growing market.

With Representation From:

  • Biogen
  • Pfizer
  • Allergan
  • Eli Lilly & Co.
  • Regeneron
  • Sanofi Genzyme
  • MedImmune
  • Terumo
  • Aptar Stelmi
  • BD
  • West
  • Ypsomed
  • rapID
  • Aspen Research
  • Exova
  • Zeon
  • Arlanxeo
  • Bosch
  • CS Fullerton
  • Eakins & Associates

Featuring Comprehensive Coverage On:

  • Key Factors in Combination Product Development: Regulatory Hurdles in Receiving PFS and Pen Approvals for Human Factors Studies
  • Patient Centric Designs For Pre-Filled Syringes
  • Next Generation Materials & Design of Pre-Filled Syringes
  • Improving Quality, Connectivity, and Cost Control in Combination Products & Autoinjectors
  • Smart Devices: Their Emerging Role in Auto-Injector Systems
  • Sterile Manufacturing of Injectables at CMO's
  • Extractables case study of resins HDPE, TPU & PEBAX
  • Managing the Materials used to Construct Pre-Filled Syringes - Selection and Supply Chain ControlLatest Market Trends and Needs for PFS
  • Overcoming Complex Requirements for Biologic Drug Delivery
  • And Much More!

Early Bird Special: Register by February 1st and Receive a $200 Discount!

Event Sponsors:

Media Partners:



Process Validation Summit 2017

May 18-19, 2017, Philadelphia, PA

Are you compliant with FDA requirements for process validation? This two-day intensive summit brings together industry leaders to help you exceed regulatory thresholds and avoid costly FDA inspection findings.

With Representation From:

  • FDA
  • Abbott
  • Bayer
  • Genzyme
  • GSK
  • QPharma
  • Patheon
  • Pfizer
  • Arlenda
  • Snee Associates
  • PharmaTech Associates
  • Compliance Team Inc
  • ResMedica
  • Stat4Ward
  • Takeda
  • BergumSTATS
  • TARIS Biomedical
  • Tunnell Consult

Featuring Comprehensive Coverage On:

  • FDA Process Validation and Risk Management Approaches
  • Lifecycle Approach to Process Validation
  • Global Technology Transfer and Process Validation
  • Achieving the Business and Compliance Benefits of Quality by Design (QbD) and Continued Process Verification (CPV)
  • Legacy Products - From Retrospective to Prospective Process Validation
  • Validation Sampling Plans and Statistical Process Control
  • Cost-effective Process Validation Lifecycle Management
  • Implementing a Comprehensive Strategy for Process Validation: Stage 3, Continued Process Verification
  • Establishing a Continuum of Criticality for Process Parameters and Quality Attributes Throughout the Lifecycle
  • Process Control Strategy and Process Performance Qualification of a Drug/Device Combination Product
  • The Drug Supply Chain Security Act-How Does it Relate to Validation?
  • And Much More!

Early Bird Special: Register by March 15th and Save $200!

Event Sponsors:



Transdermal and Intradermal Drug Delivery Systems, 2017

Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines

September 28-29, 2017, Racquet Club of Philadelphia, PA

The growing interest in alternative routes of drug administration has experts predicting that the market for transdermal and intradermal drug delivery systems will exceed $25 billion by 2018. The industry is on the threshold of bringing into commercial production a new generation of transformative TDD and IDD therapies and delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

20 Featured Speakers, Including:

  • Thean Yeoh, Pfizer
  • Ryan Donnelly, Queens University, Belfast
  • Bobby Singh, Corium
  • Lisa Dick, 3M
  • Ajay Banga, Mercer University
  • Narasimha Murthy, Ole Miss
  • Yash Kapoor, Merck
  • Mikolaj Milewski, Merck

With Comprehensive Coverage on:

  • Key Formulation Considerations for Skin-Mediated Therapies and Vaccines
  • Latest Advances in Microneedle Technology for Biologics
  • Optimizing TDD & IDD for Efficacious Delivery and Patient Compliance
  • Novel TD Patch Designs and Technologies
  • Computational Modeling for Bioavailability in TDD & IDD Systems
  • Heat Effects and IVIVC in Transdermal and Topical Drug Delivery
  • In Vitro Permeation Testing of Dermal Products
  • Understanding Regulatory Issues & Requirements for TDD & IDD Systems, including Combination Drug Guidelines, Residual Drug Disposal, Cold Flow, and Adhesion
  • Overcoming Barriers to Large Molecule Delivery and Expanding the Range of Compounds for Use in TDD & IDD
  • PK/PD Modeling for TDDS and IDDS
  • Scale-Up to Manufacture of TDDS and IDDS
  • Risk-Based Strategies for TDD & IDD System Design
  • Mechanisms of Dermal and Transdermal Absorption of Drugs
  • In Vitro Release Studies for TDD & IDD

Full Conference Agenda Coming Soon!

Pre-Conference Special: Register Now & Receive a Pre-Conference Rate of Only $995!

Event Sponsor:

Media Partner:



Workshop


Extractables & Leachables Practical Workshop

How to Apply USP Requirements to Design and Execute Extractable and Leachable Studies

September 27, 2017, Racquet Club of Philadelphia, PA

The workshop will discuss different analytical approaches related to extractable and leachable testing. Practical recommendations will be presented for designing and executing controlled ex- tractions. Analytical solutions will be explained according to the latest regulatory expectations. The workshop will provide practical guidance and case studies from start to completion.

Upcoming Events

Lyophilization Forum, October 4-5, 2017

Philadelphia, PA

Cleaning Validation Summit, October 2-3, 2017

Philadelphia, PA

Why PharmaEd?

Profitable Networking

Industry innovators and established professionals meet to share ideas, forge relationships, and imagine new opportunities.

Experience You Trust

Our team has over four decades of combined experience producing conferences and delivering real value to the pharma industry.

An Industry Leader

Pharma Ed has collaborated with over 250 companies and organizations to produce some of the most informative meetings in the industry.

Our Mission

To deliver the most current, market-driven information to meet your research, product development, regulatory, quality assurance, and technical needs.

Relevant Training

Cutting-edge knowledge drawn from top pharmaceutical, biotech, and academic experts.

Sponsorship Opportunities!

Sponsor a PharmaEd event and set your business apart!

CLICK HERE TO LEARN MORE

What People Are Saying About
Pharma Ed Events

"A Fantastic meeting. I was interested in so many of the talks and I met several clients - current and potential."
- Principal Scientist, Aptuit SSCI

"I really enjoyed the meeting... Stronger speakers and more in depth coverage than some of the others on the market."
- Director, Emerson Resources, Inc.

"Thank you again for such an excellent program - it was very informative and enjoyable."
- Sr. Principal Scientist, Bausch + Lomb

"I go to a lot of conferences, and this was an excellent one."
- Sr. Scientist, Boehringer Ingelheim

"Great audience, with good choice of speakers. Would love to attend again."
- Principal Scientist, Pfizer

"I greatly enjoyed the conference. I found the topics relevant and containing great content. I look forward to bringing the knowledge and principles to my role in R&D."
- Manager, CSL Behring

"I was very pleased with the material presented, and the expertise of the presenters. I will be taking much valuable/applicable knowledge back to my company."
- QA Director, Biothera

"Each and every presentation contained information that I found to be useful and relevant and many presentations left me with ideas and concepts that I look forward to considering in greater detail."
- Distinguished Scientist, Baxter

"The presentations & experience of the presenters was very instructive & helpful toward building my programs."
- QA/Corporate Director, Medicago, Inc.

"This is a valuable conference, with many expert speakers."
- Product Manager, EMD Millipore

"I really enjoyed it. I feel engaged and like there is a lot to learn."
- Assoc. Scientist, Bristol-Myers Squibb

"Very good conference with knowledgeable presenters, good feedback, and 'real world' examples/takeaways."
- Assoc. Director of PV, Shire

"Great mix of topics and excellent networking sessions."
- Deputy Director, Sanofi Pasteur

"Very useful conference for us. Learned a lot from all the presentations."
- Scientist I, Amneal Pharmaceuticals

"I am new to the med device E/L scene, so I attended as a learning opportunity and to begin to get up to speed. I feel the conference was very informative and balanced various subject areas as well. I'll definitely plan on attending again."
- Research Toxicologist, NSF International